View in EDS

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.

Saved in:
Bibliographic Details
Title: The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
Authors: Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: education@esmo.org., Martins-Branco D; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland., Beal JR; Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy., Coleman N; School of Medicine, Trinity College Dublin, Dublin; Medical Oncology Department, St. James's Hospital, Dublin; Trinity St. James's Cancer Institute, Dublin, Ireland., Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City; Weill Cornell Medical College, New York City., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham; Duke Cancer Institute, Duke University, Durham, USA., Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif, France., Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre., Bibeau F; Service d'Anatomie Pathologique, CHU Besançon, Université de Bourgogne Franche-Comté, Besançon, France., Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Kummar S; Division of Hematology and Medical Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland., Kurzrock R; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, USA., Limaye S; Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital & Research Centre, Mumbai, India., Loges S; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), German Cancer Consortium (DKTK), Heidelberg, Germany., Marabelle A; Drug Development Department (DITEP) and Laboratory for Translational Research in Immunotherapy (LRTI), Gustave Roussy, INSERM U1015 & CIC1428, Université Paris-Saclay, Villejuif, France., Marchió C; Department of Medical Sciences, University of Turin, Turin; Division of Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rodon J; Department of Investigational Cancer Therapeutics, UT MD Anderson, Houston, USA., Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia., Pentheroudakis G; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland., Subbiah V; Early-Phase Drug Development, Sarah Cannon Research Institute (SCRI), Nashville, USA.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov; Vol. 35 (11), pp. 936-953. Date of Electronic Publication: 2024 Aug 25.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39187421
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Westphalen+CB%22">Westphalen CB</searchLink>; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: education@esmo.org.<br /><searchLink fieldCode="AU" term="%22Martins-Branco+D%22">Martins-Branco D</searchLink>; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Beal+JR%22">Beal JR</searchLink>; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Cardone+C%22">Cardone C</searchLink>; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Coleman+N%22">Coleman N</searchLink>; School of Medicine, Trinity College Dublin, Dublin; Medical Oncology Department, St. James's Hospital, Dublin; Trinity St. James's Cancer Institute, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Schram+AM%22">Schram AM</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City; Weill Cornell Medical College, New York City.<br /><searchLink fieldCode="AU" term="%22Halabi+S%22">Halabi S</searchLink>; Department of Biostatistics and Bioinformatics, Duke University, Durham; Duke Cancer Institute, Duke University, Durham, USA.<br /><searchLink fieldCode="AU" term="%22Michiels+S%22">Michiels S</searchLink>; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Yap+C%22">Yap C</searchLink>; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22André+F%22">André F</searchLink>; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre.<br /><searchLink fieldCode="AU" term="%22Bibeau+F%22">Bibeau F</searchLink>; Service d'Anatomie Pathologique, CHU Besançon, Université de Bourgogne Franche-Comté, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Garralda+E%22">Garralda E</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Kummar+S%22">Kummar S</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Kurzrock+R%22">Kurzrock R</searchLink>; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, USA.<br /><searchLink fieldCode="AU" term="%22Limaye+S%22">Limaye S</searchLink>; Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital & Research Centre, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Loges+S%22">Loges S</searchLink>; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Marabelle+A%22">Marabelle A</searchLink>; Drug Development Department (DITEP) and Laboratory for Translational Research in Immunotherapy (LRTI), Gustave Roussy, INSERM U1015 & CIC1428, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Marchió+C%22">Marchió C</searchLink>; Department of Medical Sciences, University of Turin, Turin; Division of Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.<br /><searchLink fieldCode="AU" term="%22Mateo+J%22">Mateo J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodon+J%22">Rodon J</searchLink>; Department of Investigational Cancer Therapeutics, UT MD Anderson, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Spanic+T%22">Spanic T</searchLink>; Europa Donna Slovenia, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Pentheroudakis+G%22">Pentheroudakis G</searchLink>; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; Early-Phase Drug Development, Sarah Cannon Research Institute (SCRI), Nashville, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2024 Nov; Vol. 35 (11), pp. 936-953. <i>Date of Electronic Publication: </i>2024 Aug 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39187421
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.07.730
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 936
    Titles:
      – TitleFull: The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Westphalen CB
      – PersonEntity:
          Name:
            NameFull: Martins-Branco D
      – PersonEntity:
          Name:
            NameFull: Beal JR
      – PersonEntity:
          Name:
            NameFull: Cardone C
      – PersonEntity:
          Name:
            NameFull: Coleman N
      – PersonEntity:
          Name:
            NameFull: Schram AM
      – PersonEntity:
          Name:
            NameFull: Halabi S
      – PersonEntity:
          Name:
            NameFull: Michiels S
      – PersonEntity:
          Name:
            NameFull: Yap C
      – PersonEntity:
          Name:
            NameFull: André F
      – PersonEntity:
          Name:
            NameFull: Bibeau F
      – PersonEntity:
          Name:
            NameFull: Curigliano G
      – PersonEntity:
          Name:
            NameFull: Garralda E
      – PersonEntity:
          Name:
            NameFull: Kummar S
      – PersonEntity:
          Name:
            NameFull: Kurzrock R
      – PersonEntity:
          Name:
            NameFull: Limaye S
      – PersonEntity:
          Name:
            NameFull: Loges S
      – PersonEntity:
          Name:
            NameFull: Marabelle A
      – PersonEntity:
          Name:
            NameFull: Marchió C
      – PersonEntity:
          Name:
            NameFull: Mateo J
      – PersonEntity:
          Name:
            NameFull: Rodon J
      – PersonEntity:
          Name:
            NameFull: Spanic T
      – PersonEntity:
          Name:
            NameFull: Pentheroudakis G
      – PersonEntity:
          Name:
            NameFull: Subbiah V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1